Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...

Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA ® (darolutamide; n=55) ...

More often than not, pulling data from the internet can be a major pain in the behind. It lulls you into a false sense of accomplishment, since downloading a web page is the easy part. But when you ...

Area residents will no longer have to travel far from home for advanced cancer treatment, which is now available locally.

Ubiquiti released a new security bulletin detailing fixes for six security issues, including one rated 9.1 (critical) and one scoring a perfect 10.0 on the CVE risk scale. The vulnerabilities ...

Raytheon's Tucson operation is working on a composable motor aimed at addressing production bottlenecks in missile programs.

Learn how Claude Code's new workflow feature reduces token tax, improves reliability, and automates complex developer tasks efficiently.

Newly promoted Assistant City Manager Michael Cassata has played a key role in many of the city’s recent economic development ...

U.S. military contractors will need at least three years to replenish stockpiles of three key weapons systems used in the ...

National security doesn’t begin at the Pentagon. It begins at the factories and power lines that keep America’s defense ...

Spyware attacks that target journalists, human rights defenders, and political dissidents have become common, and major tech companies now offer opt-in ...